Shots: Immunogen to receive $65M as total deal value and OMERS to get royalties on sales of Kadcyla In 2015, Immunogen & IRH collaborated for Kadcyla’s royalty for $200M, where […]readmore
Tags : (ado-trastuzumab emtansine)